Presentation is loading. Please wait.

Presentation is loading. Please wait.

Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency  Cihan Papan, MD, Beate Hagl, PhD,

Published byAleesha Copeland Modified over 6 years ago

Similar presentations

Presentation on theme: "Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency  Cihan Papan, MD, Beate Hagl, PhD,"— Presentation transcript:

1 Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency  Cihan Papan, MD, Beate Hagl, PhD, Valerie Heinz, MD, Michael H. Albert, MD, Oliver Ehrt, MD, Julie Sawalle-Belohradsky, Jens Neumann, MD, Martin Ries, MD, Philip Bufler, MD, Andreas Wollenberg, MD, Ellen D. Renner, MD  Journal of Allergy and Clinical Immunology  Volume 133, Issue 5, Pages (May 2014) DOI: /j.jaci Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 A, Tumorous blepharoconjunctivitis before IFN-α therapy. Continuous improvement with residuae of the herpetic erosions visible 96 hours (B), 2 weeks (C), and 10 weeks (D) after the initiation of weekly IFN-α injections. E, Upper eyelid biopsy revealing epidermis with florid ulceration (hematoxylin and eosin, 1:100). F, Higher magnification (hematoxylin and eosin, 1:200) shows coagulative necrosis and cell debris (), granulation tissue in ulcer's base (), and regenerative changes of intact epithelium at margins of the lesion (). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Model of beneficial IFN-α effects on immunity in DOCK8 deficiency. B, B cell; CTL, cytotoxic T lymphocyte; NK, natural killer cell; STAT3, signal transducer and activator of transcription 3. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency  Cihan Papan, MD, Beate Hagl, PhD,"

Similar presentations

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Topically applied ascorbic acid solution for the treatment of basal cell carcinoma (BCC)  Péter Holló, MD, PhD, Hajnalka Jókai, MD, PhD, Judit Hársing,

Topically applied ascorbic acid solution for the treatment of basal cell carcinoma (BCC)  Péter Holló, MD, PhD, Hajnalka Jókai, MD, PhD, Judit Hársing,
Doina M. Racila, MD, Joel N. Kline, MD, MSc 

Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Plasmacytoid dendritic cell depletion in DOCK8 deficiency: Rescue of severe herpetic infections with IFN-α 2b therapy  Sevgi Keles, MD, Haifa H. Jabara,

Plasmacytoid dendritic cell depletion in DOCK8 deficiency: Rescue of severe herpetic infections with IFN-α 2b therapy  Sevgi Keles, MD, Haifa H. Jabara,
Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES)  Benedikt D. Spielberger, Cristina.

Challenges of genetic counseling in patients with autosomal dominant diseases, such as the hyper-IgE syndrome (STAT3-HIES)  Benedikt D. Spielberger, Cristina.
Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency  Cihan Papan, MD, Beate Hagl, PhD,

Beneficial IFN-α treatment of tumorous herpes simplex blepharoconjunctivitis in dedicator of cytokinesis 8 deficiency  Cihan Papan, MD, Beate Hagl, PhD,
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Advances in food allergy in 2015

Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Atopic dermatitis: Age and race do matter!

Atopic dermatitis: Age and race do matter!
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema  Dagmar Simon, MD, Jennifer Wittwer, MD, Ganna Kostylina,

Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema  Dagmar Simon, MD, Jennifer Wittwer, MD, Ganna Kostylina,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents

Desensitization to Chemotherapeutic Agents
Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 

Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Pathergy response to skin prick testing

Pathergy response to skin prick testing
Asthma therapy and airway remodeling

Asthma therapy and airway remodeling
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis  George Philip, MD, Janet van Adelsberg, MD, Thomas Loeys, PhD, Nancy.

Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis  George Philip, MD, Janet van Adelsberg, MD, Thomas Loeys, PhD, Nancy.

Similar presentations

Ads by Google